TR199801613T2 - Kontrast ajanlar�nda ya da bunlarla ilgili iyile�tirmeler. - Google Patents

Kontrast ajanlar�nda ya da bunlarla ilgili iyile�tirmeler.

Info

Publication number
TR199801613T2
TR199801613T2 TR1998/01613T TR9801613T TR199801613T2 TR 199801613 T2 TR199801613 T2 TR 199801613T2 TR 1998/01613 T TR1998/01613 T TR 1998/01613T TR 9801613 T TR9801613 T TR 9801613T TR 199801613 T2 TR199801613 T2 TR 199801613T2
Authority
TR
Turkey
Prior art keywords
contrast agents
microbubbles
stabilized
product
dispersions
Prior art date
Application number
TR1998/01613T
Other languages
English (en)
Turkish (tr)
Inventor
Dugstad Harald
Klaveness Jo
Rongved Pal
Skurtveit Roald
Braenden Jorun
Original Assignee
Nycomed Imaging A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603466.5A external-priority patent/GB9603466D0/en
Priority claimed from GBGB9611894.8A external-priority patent/GB9611894D0/en
Priority claimed from GBGB9625663.1A external-priority patent/GB9625663D0/en
Application filed by Nycomed Imaging A/S filed Critical Nycomed Imaging A/S
Publication of TR199801613T2 publication Critical patent/TR199801613T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasonic imaging preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasonic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasonic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasonic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasonic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/227—Liposomes, lipoprotein vesicles, e.g. LDL or HDL lipoproteins, micelles, e.g. phospholipidic or polymeric
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
TR1998/01613T 1996-02-19 1997-02-19 Kontrast ajanlar�nda ya da bunlarla ilgili iyile�tirmeler. TR199801613T2 (xx)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9603466.5A GB9603466D0 (en) 1996-02-19 1996-02-19 Improvements in or relating to contrast agents
GBGB9611894.8A GB9611894D0 (en) 1996-06-07 1996-06-07 Improvements in or relating to contrast agents
GBGB9625663.1A GB9625663D0 (en) 1996-12-11 1996-12-11 Improvements in or relating to contrast agents

Publications (1)

Publication Number Publication Date
TR199801613T2 true TR199801613T2 (xx) 1998-11-23

Family

ID=27268137

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/01613T TR199801613T2 (xx) 1996-02-19 1997-02-19 Kontrast ajanlar�nda ya da bunlarla ilgili iyile�tirmeler.

Country Status (24)

Country Link
US (4) US6221337B1 (cg-RX-API-DMAC7.html)
EP (2) EP1331013A3 (cg-RX-API-DMAC7.html)
JP (1) JP4418033B2 (cg-RX-API-DMAC7.html)
KR (1) KR100500334B1 (cg-RX-API-DMAC7.html)
CN (1) CN1278740C (cg-RX-API-DMAC7.html)
AP (1) AP890A (cg-RX-API-DMAC7.html)
AT (1) ATE238072T1 (cg-RX-API-DMAC7.html)
AU (1) AU726503B2 (cg-RX-API-DMAC7.html)
BG (1) BG102758A (cg-RX-API-DMAC7.html)
CA (1) CA2246779C (cg-RX-API-DMAC7.html)
CZ (1) CZ293986B6 (cg-RX-API-DMAC7.html)
DE (1) DE69721235T2 (cg-RX-API-DMAC7.html)
EA (1) EA001135B1 (cg-RX-API-DMAC7.html)
EE (1) EE04224B1 (cg-RX-API-DMAC7.html)
ES (1) ES2197986T3 (cg-RX-API-DMAC7.html)
HU (1) HU229090B1 (cg-RX-API-DMAC7.html)
IL (1) IL125748A (cg-RX-API-DMAC7.html)
NZ (1) NZ331509A (cg-RX-API-DMAC7.html)
OA (1) OA10839A (cg-RX-API-DMAC7.html)
PL (1) PL328406A1 (cg-RX-API-DMAC7.html)
PT (1) PT881915E (cg-RX-API-DMAC7.html)
SK (1) SK284200B6 (cg-RX-API-DMAC7.html)
TR (1) TR199801613T2 (cg-RX-API-DMAC7.html)
WO (1) WO1997029783A1 (cg-RX-API-DMAC7.html)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100593873B1 (ko) * 1996-08-02 2006-07-03 지이 헬스케어 에이에스 조영제
AU784367B2 (en) * 1996-08-02 2006-03-16 Ge Healthcare As Improvements in or relating to contrast agents
ATE252916T1 (de) * 1997-08-12 2003-11-15 Bracco Research Sa Verabreichbare formulierugen und ihre anwendung in mri
GB9717476D0 (en) * 1997-08-18 1997-10-22 Nycomed Imaging As Process
GB9717588D0 (en) * 1997-08-19 1997-10-22 Nycomed Imaging As Improvements in or relating to contrast agents
GB9717542D0 (en) * 1997-08-19 1997-10-22 Nycomed Imaging As Process
GB9717589D0 (en) * 1997-08-19 1997-10-22 Nycomed Imaging As Improvements in or relating to contrast agents
GB9726773D0 (en) 1997-12-18 1998-02-18 Nycomed Imaging As Improvements in or relating to ultrasonagraphy
WO1999055837A2 (en) * 1998-04-28 1999-11-04 Nycomed Imaging As Improvements in or relating to separation processes
GB9813568D0 (en) 1998-06-23 1998-08-19 Nycomed Imaging As Improvements in or relating to cardiac imaging
US6514209B1 (en) 1999-06-07 2003-02-04 Drexel University Method of enhancing ultrasonic techniques via measurement of ultraharmonic signals
US20030103960A1 (en) * 1999-12-22 2003-06-05 Pierre Philippart Sealant and bone generating product
JP5078212B2 (ja) 2000-06-02 2012-11-21 ブラッコ・スイス・ソシエテ・アノニム 内皮細胞を標的とするための化合物、それを含む組成物およびその使用方法
NO20004795D0 (no) 2000-09-26 2000-09-26 Nycomed Imaging As Peptidbaserte forbindelser
KR100373712B1 (ko) * 2000-12-23 2003-02-25 사회복지법인삼성생명공익재단(삼성서울병원) 초음파 조영제 및 그의 제조방법
US6984373B2 (en) 2000-12-23 2006-01-10 Dyax Corp. Fibrin binding moieties useful as imaging agents
ATE376803T1 (de) 2001-04-06 2007-11-15 Bracco Research Sa Vorrichtung zur messung lokaler physikalischer parameter in einem flüssigkeitsgefüllten hohlraum
WO2003063824A2 (en) * 2002-02-01 2003-08-07 Shimoda Biotech (Pty) Ltd Pharmaceutical composition
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
WO2004065621A1 (en) 2002-03-01 2004-08-05 Dyax Corp. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
SI2301587T1 (sl) 2002-03-01 2014-11-28 Dyax Corp. KDR in VEGF/KDR vezavni peptidi in njihova uporaba pri diagnozi
US7211240B2 (en) 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
NO20024755D0 (no) * 2002-10-03 2002-10-03 Amersham Health As Metode
CA2504668A1 (en) 2002-11-29 2004-06-17 Amersham Health As Ultrasound triggering method
EP1590006B1 (en) * 2003-02-04 2010-09-08 Bracco Suisse SA Ultrasound contrast agents and process for the preparation thereof
US20070128117A1 (en) * 2003-02-04 2007-06-07 Bracco International B.V. Ultrasound contrast agents and process for the preparation thereof
ES2557286T3 (es) 2003-03-03 2016-01-25 Dyax Corp. Usos de péptidos que se unen específicamente al receptor del HGF (cMet)
EP1643972A4 (en) * 2003-06-27 2010-01-20 Smithkline Beecham Corp STABILIZED LIPOSOMAL TOPOTECAN COMPOSITION AND METHOD
US20050019379A1 (en) 2003-07-22 2005-01-27 Kimberly-Clark Worldwide, Inc. Wipe and methods for improving skin health
NO20035401D0 (no) * 2003-12-04 2003-12-04 Amersham Health As Metode
CA2547024C (en) * 2003-12-22 2013-12-17 Bracco Research Sa Gas-filled microvesicle assembly for contrast imaging
ES2531751T3 (es) * 2003-12-22 2015-03-18 Bracco Suisse Sa Montaje de microvesícula rellena de gas con componente activo para imagenología de contraste
US7025726B2 (en) 2004-01-22 2006-04-11 The Regents Of The University Of Nebraska Detection of endothelial dysfunction by ultrasonic imaging
WO2006018433A1 (en) 2004-08-18 2006-02-23 Bracco Research Sa Gas-filled microvesicles composition for contrast imaging
WO2006044996A2 (en) * 2004-10-15 2006-04-27 The Trustees Of Columbia University In The City Of New York System and method for automated boundary detection of body structures
WO2006044997A2 (en) * 2004-10-15 2006-04-27 The Trustees Of Columbia University In The City Of New York System and method for localized measurement and imaging of viscosity of tissues
CN100574811C (zh) * 2005-01-10 2009-12-30 重庆海扶(Hifu)技术有限公司 一种高强度聚焦超声治疗用微粒类助剂及其应用
CN100574809C (zh) * 2005-01-10 2009-12-30 重庆海扶(Hifu)技术有限公司 一种高强度聚焦超声治疗用氟碳乳剂类助剂及其应用
CN100427142C (zh) * 2005-01-10 2008-10-22 重庆海扶(Hifu)技术有限公司 一种高强度聚焦超声治疗用助剂及其筛选方法
US10687785B2 (en) 2005-05-12 2020-06-23 The Trustees Of Columbia Univeristy In The City Of New York System and method for electromechanical activation of arrhythmias
EP1937151A4 (en) * 2005-09-19 2011-07-06 Univ Columbia Systems and methods for opening of the blood-brain barrier of a subject using ultrasound
ES2428964T3 (es) 2005-12-09 2013-11-12 Bracco Suisse Sa Conjugados de vectores específicos de una diana-fosfolípidos
EP1797919A1 (en) 2005-12-16 2007-06-20 Bracco Research S.A. Liquid transfer device for medical dispensing containers
US20070179094A1 (en) 2006-01-31 2007-08-02 Bayer Schering Pharma Ag Modulation of MDL-1 activity for treatment of inflammatory disease
CA2659645C (en) 2006-08-01 2015-06-30 Martijn E. Frijlink Pulse inversion sequences for nonlinear imaging
US8150128B2 (en) * 2006-08-30 2012-04-03 The Trustees Of Columbia University In The City Of New York Systems and method for composite elastography and wave imaging
AU2007293888B2 (en) 2006-09-05 2013-05-02 Bracco Suisse S.A. Gas-filled microvesicles with polymer-modified lipids
EP2005970A1 (de) 2007-06-22 2008-12-24 Berlin Science Partners GmbH i.V. Bildgebende Diagnostik durch Kombination von Kontrastmitteln
JP2010005512A (ja) * 2008-06-25 2010-01-14 Kao Corp 微細気泡前駆体組成物
GB0811856D0 (en) * 2008-06-27 2008-07-30 Ucl Business Plc Magnetic microbubbles, methods of preparing them and their uses
WO2010014977A1 (en) 2008-08-01 2010-02-04 The Trustees Of Columbia University In The City Of New York Systems and methods for matching and imaging tissue characteristics
WO2010030819A1 (en) 2008-09-10 2010-03-18 The Trustees Of Columbia University In The City Of New York Systems and methods for opening a tissue
EP2334239A4 (en) * 2008-09-10 2011-10-19 Univ Columbia INSULATION OF MICROBUMS OF A SPECIFIC SIZE OF POLYDISPERSE MICROBUBBLES
US10058837B2 (en) 2009-08-28 2018-08-28 The Trustees Of Columbia University In The City Of New York Systems, methods, and devices for production of gas-filled microbubbles
EP2477550A4 (en) * 2009-09-15 2013-12-04 Univ Columbia SYSTEMS, METHODS AND DEVICES FOR MICROBUBBLES
EP2480144B1 (en) 2009-09-21 2024-03-06 The Trustees of Columbia University in the City of New York Systems for opening of a tissue barrier
WO2011035254A1 (en) * 2009-09-21 2011-03-24 Drexel University Stabilized ultrasound contrast agent
US8834846B2 (en) 2010-05-06 2014-09-16 Bruker Biospin Corporation Fluorescent NIRF activatable probes for disease detection
US9265483B2 (en) 2010-08-06 2016-02-23 The Trustees Of Columbia University In The City Of New York Medical imaging contrast devices, methods, and systems
WO2012136813A2 (en) 2011-04-07 2012-10-11 Universitetet I Oslo Agents for medical radar diagnosis
WO2012162664A1 (en) 2011-05-26 2012-11-29 The Trustees Of Columbia University In The City Of New York Systems and methods for opening of a tissue barrier in primates
BR112014026783B1 (pt) 2012-04-30 2020-12-15 Ge Healthcare As Processo para preparar um recipiente enchido com uma composição
EP2864033B1 (en) 2012-06-26 2016-04-06 GE Healthcare AS Preparation of composition comprising gas microbubbles
WO2014059170A1 (en) 2012-10-10 2014-04-17 The Trustees Of Columbia University In The City Of New York Systems and methods for mechanical mapping of cardiac rhythm
JP6313329B2 (ja) 2012-12-21 2018-04-18 ブラッコ・スイス・ソシエテ・アノニムＢｒａｃｃｏ Ｓｕｉｓｓｅ ＳＡ ガス封入マイクロベシクル
US9255907B2 (en) 2013-03-14 2016-02-09 Empire Technology Development Llc Identification of surgical smoke
US10017551B2 (en) 2013-03-15 2018-07-10 The Regents Of The University Of California Peptides having reduced toxicity that stimulate cholesterol efflux
US9247921B2 (en) 2013-06-07 2016-02-02 The Trustees Of Columbia University In The City Of New York Systems and methods of high frame rate streaming for treatment monitoring
US10322178B2 (en) 2013-08-09 2019-06-18 The Trustees Of Columbia University In The City Of New York Systems and methods for targeted drug delivery
US10028723B2 (en) 2013-09-03 2018-07-24 The Trustees Of Columbia University In The City Of New York Systems and methods for real-time, transcranial monitoring of blood-brain barrier opening
GB201405735D0 (en) * 2014-03-31 2014-05-14 Ge Healthcare As Ultrasound precursor preparation method
ES2726924T3 (es) 2014-12-18 2019-10-10 Bracco Suisse Sa Formulación de microvesículas dirigidas rellenas de gas
WO2016199430A1 (ja) * 2015-06-10 2016-12-15 学校法人帝京大学 セラノスティクス用のバブル製剤（ｔｂ）及びその使用方法
CN107233583B (zh) * 2016-03-29 2020-04-24 北京飞锐达医疗科技有限公司 一种具有超长持续时间的超声造影剂及其制备方法
GB201821049D0 (en) * 2018-12-21 2019-02-06 Ge Healthcare As Ultrasound contrast agent and methods for use therof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585112A (en) * 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US5445813A (en) * 1992-11-02 1995-08-29 Bracco International B.V. Stable microbubble suspensions as enhancement agents for ultrasound echography
IN172208B (cg-RX-API-DMAC7.html) * 1990-04-02 1993-05-01 Sint Sa
DE4100470A1 (de) * 1991-01-09 1992-07-16 Byk Gulden Lomberg Chem Fab Echokontrastmittel
GB9106673D0 (en) * 1991-03-28 1991-05-15 Hafslund Nycomed As Improvements in or relating to contrast agents
DE4328642A1 (de) * 1993-08-26 1995-03-02 Byk Gulden Lomberg Chem Fab Ultraschallkontrastmittel
GB9511488D0 (en) * 1995-06-07 1995-08-02 Nycomed Imaging As Improvements in or relating to contrast agents
US5846517A (en) * 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator

Also Published As

Publication number Publication date
ES2197986T3 (es) 2004-01-16
DE69721235T2 (de) 2004-02-05
EP0881915B1 (en) 2003-04-23
WO1997029783A1 (en) 1997-08-21
HK1014872A1 (en) 1999-10-08
CN1213972A (zh) 1999-04-14
BG102758A (en) 1999-09-30
CN1278740C (zh) 2006-10-11
KR100500334B1 (ko) 2005-09-09
US20050201942A1 (en) 2005-09-15
KR19990082669A (ko) 1999-11-25
CZ262598A3 (cs) 1999-05-12
CA2246779A1 (en) 1997-08-21
US6221337B1 (en) 2001-04-24
HU229090B1 (en) 2013-07-29
OA10839A (en) 2001-08-13
PL328406A1 (en) 1999-01-18
CA2246779C (en) 2008-04-29
CZ293986B6 (cs) 2004-09-15
ATE238072T1 (de) 2003-05-15
JP2000511510A (ja) 2000-09-05
AP890A (en) 2000-11-13
SK284200B6 (sk) 2004-10-05
AU726503B2 (en) 2000-11-09
NZ331509A (en) 2000-04-28
EA001135B1 (ru) 2000-10-30
HUP9900813A3 (en) 1999-11-29
EE04224B1 (et) 2004-02-16
HUP9900813A2 (hu) 1999-07-28
SK112698A3 (en) 1999-04-13
IL125748A (en) 2002-05-23
US20010010811A1 (en) 2001-08-02
EP0881915A1 (en) 1998-12-09
AP9801319A0 (en) 1998-09-30
US20030202942A1 (en) 2003-10-30
EP1331013A2 (en) 2003-07-30
EA199800745A1 (ru) 1999-02-25
PT881915E (pt) 2003-09-30
EE9800249A (et) 1999-02-15
JP4418033B2 (ja) 2010-02-17
EP1331013A3 (en) 2004-03-24
DE69721235D1 (de) 2003-05-28
IL125748A0 (en) 1999-04-11
AU1884797A (en) 1997-09-02

Similar Documents

Publication Publication Date Title
Rosing et al. The role of activated human platelets in prothrombin and factor X activation
Madeira et al. Activation energies of the ATPase activity of sarcoplasmic reticulum
EA199800745A1 (ru) Устовершенствования в области контрастных агентов
Hanover et al. Synthesis of N-and O-linked glycopeptides in oviduct membrane preparations.
GB9809084D0 (en) Improvements in or relating to diagnostic/therapeutic agents
Izgu et al. N‑Carboxyanhydride-Mediated Fatty Acylation of Amino Acids and Peptides for Functionalization of Protocell Membranes
Griebel et al. Metabolism of poly-β-hydroxybutyrate: effect of mild alkaline extraction on native poly-β-hydroxybutyrate granules
Fischer et al. Comparison of ΔpH‐and Δφ‐driven ATP synthesis catalyzed by the H+‐ATPases from Escherichia coli or chloroplasts reconstituted into liposomes
Jain et al. Interfacial catalysis by phospholipase A2: monomeric enzyme is fully catalytically active at the bilayer interface
Upreti et al. Action of phospholipase A2 on unmodified phosphatidylcholine bilayers: organizational defects are preferred sites of action
Tatulian et al. Structural changes in a secretory phospholipase A 2 Induced by membrane binding: a clue to interfacial activation?
AU3780497A (en) Improvements in or relating to contrast agents
BR9807043A (pt) Mistura estabilizada que compreende fibrinogênio
BR0012443A (pt) Lipolìmero neutro e composições de lipossoma contendo o mesmo
van Dieijen et al. Assembly of the intrinsic factor X activating complex–interactions between factor IXa, factor VIIIa and phospholipid
Turina et al. Activation of the H (+)-ATP synthase in the photosynthetic bacterium Rhodobacter capsulatus.
Attwood et al. The phospholipid-dependence of uridine diphosphate glucuronyltransferase. Reactivation of phospholipase A-inactivated enzyme by phospholipids and detergents
Hesler et al. Transverse-plane topography of long-chain acyl-CoA synthetase in the mitochondrial outer membrane.
Almeida et al. Effect of short-chain primary alcohols on fluidity and activity of sarcoplasmic reticulum membranes
Pedersen et al. Phospholipase-like myotoxins induce rapid membrane leakage of non-hydrolyzable ether-lipid liposomes
GOVERS‐RIEMSLAG et al. Prothrombin activation on dioleoylphosphatidylcholine membranes
Lecompte et al. Membrane penetration of bovine factor V and Va detected by labeling with 5-iodonaphthalene-1-azide.
Kiss et al. Investigation of the active site of the extracellular β-D-xylosidase from Aspergillus carbonarius
Verri et al. H+/glycyl-glycine cotransport in eel intestinal brush-border membrane vesicles: studies with the pH-sensitive dye Acridine orange
Inoue et al. Miscibility of binary phospholipid mixtures under hydrated and unhydrated conditions. I. Phosphatidic acids with different acyl chain length